MDWD – mediwound ltd. - ordinary shares (US:NASDAQ)

MediWound Ltd. (NASDAQ: MDWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.

MediWound Ltd. (MDWD) Q4 2022 Earnings Call Transcript [Seeking Alpha]

MediWound names industry veteran as CFO [Seeking Alpha]

MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update

MediWound Announces the Appointment of Hani Luxenburg as Chief Financial Officer

MediWound Expands its Global Leadership Team to Help Drive Company’s Future Growth

MediWound to Report Fourth Quarter and Year-End 2022 Financial Results

MediWound to Present Corporate Highlights at Upcoming Investor Conferences

MediWound Ltd. (NASDAQ: MDWD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.

MediWound Announces Closing of $27.5 Million Registered Direct Offering of Ordinary Shares

MediWound Announces $27.5 Million Registered Direct Offering of Ordinary Shares Priced At-The-Market

MediWound: Gaining Traction [Seeking Alpha]

MediWound Ltd. (NASDAQ: MDWD) had its price target raised by analysts at HC Wainwright from $5.50 to $23.00. They now have a "buy" rating on the stock.